Yayın:
Treatment of infiltrating basal cell carcinoma with the combination of intralesional IFNα-2b and topical imiquimod 5% cream

Basit Görünüm
dc.contributor.buuauthorTuran, Ayşegül
dc.contributor.buuauthorSarıcaoğlu, Hayriye
dc.contributor.buuauthorBaşkan, Emel Bülbül
dc.contributor.buuauthorToker, Semra Çıkman
dc.contributor.buuauthorTunalı, Şükran
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentDermatoloji Bölümü
dc.contributor.orcid0000-0002-0144-3263
dc.contributor.researcheridAAH-1388-2021
dc.contributor.scopusid14055302400
dc.contributor.scopusid6603722836
dc.contributor.scopusid6602518817
dc.contributor.scopusid14054750900
dc.contributor.scopusid7004191748
dc.date.accessioned2022-01-19T12:43:44Z
dc.date.available2022-01-19T12:43:44Z
dc.date.issued2009-02
dc.identifier.citationTuran, A. vd. (2009). "Treatment of infiltrating basal cell carcinoma with the combination of intralesional IFNα-2b and topical imiquimod 5% cream". International Journal of Dermatology, 48(2), 214-215.
dc.identifier.endpage215
dc.identifier.issn0011-9059
dc.identifier.issue2
dc.identifier.pubmed19200213
dc.identifier.scopus2-s2.0-59149086098
dc.identifier.startpage214
dc.identifier.urihttps://doi.org/10.1111/j.1365-4632.2009.03576.x
dc.identifier.urihttps://onlinelibrary.wiley.com/doi/10.1111/j.1365-4632.2009.03576.x
dc.identifier.urihttp://hdl.handle.net/11452/24171
dc.identifier.volume48
dc.identifier.wos000262641500033
dc.indexed.wosSCIE
dc.language.isoen
dc.publisherWiley
dc.relation.journalInternational Journal of Dermatology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectInterferon
dc.subjectEfficacy
dc.subjectDermatology
dc.subject.emtreeAlpha2b interferon
dc.subject.emtreeImiquimod
dc.subject.emtreeAdult
dc.subject.emtreeBasal cell carcinoma
dc.subject.emtreeCase report
dc.subject.emtreeDisease duration
dc.subject.emtreeEdema
dc.subject.emtreeErosion
dc.subject.emtreeErythema
dc.subject.emtreeFmale
dc.subject.emtreeFlu like syndrome
dc.subject.emtreeHuman
dc.subject.emtreeHuman tissue
dc.subject.emtreeImmune response
dc.subject.emtreeLetter
dc.subject.emtreePunch biopsy
dc.subject.emtreeRemission
dc.subject.emtreeSkin crust
dc.subject.emtreeSkin disease
dc.subject.emtreeTelangiectasia
dc.subject.emtreeTreatment duration
dc.subject.emtreeVesiculation
dc.subject.meshAdministration, topical
dc.subject.meshAminoquinolines
dc.subject.meshAntineoplastic agents
dc.subject.meshCarcinoma, basal cell
dc.subject.meshDrug therapy, combination
dc.subject.meshFemale
dc.subject.meshHumans
dc.subject.meshInterferon alfa-2b
dc.subject.meshMiddle aged
dc.subject.meshNose neoplasms
dc.subject.meshSkin neoplasms
dc.subject.scopusKeratoacanthoma; Squamous Cell Carcinoma; Etretin
dc.subject.wosDermatology
dc.titleTreatment of infiltrating basal cell carcinoma with the combination of intralesional IFNα-2b and topical imiquimod 5% cream
dc.typeLetter
dc.wos.quartileQ3
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi/Dermatoloji Bölümü
local.indexed.atScopus
local.indexed.atWOS

Dosyalar

Lisanslı seri

Şimdi gösteriliyor 1 - 1 / 1
Placeholder
Ad:
license.txt
Boyut:
1.71 KB
Format:
Item-specific license agreed upon to submission
Açıklama
İndir

Koleksiyonlar

İndeksli Yayınlar / Indexed Publications